For the quarter ending 2025-09-30, EPR had $972K increase in cash & cash equivalents over the period. $132,110K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income | 66,586 | 141,446 |
| Impairment, long-lived asset, held-for-use | 0 | - |
| Impairment charges on joint ventures | 0 | - |
| Gain on sale of real estate and early ground lease termination | 8,073 | 26,163 |
| Deferred income tax benefit | -53 | -623 |
| Write off of deferred debt issuance cost | 0 | - |
| Equity in loss from joint ventures | 2,934 | -4,328 |
| Proceeds from equity method investment, distribution | 0 | 11 |
| Financing receivable, credit loss, expense (reversal) | 9,117 | 345 |
| Asset impairment charges | - | 0 |
| Depreciation and amortization | 42,409 | 83,169 |
| Amortization of deferred financing costs | 2,120 | 4,308 |
| Amortization of above/below market leases and tenant allowances, net | -81 | -162 |
| Share-based payment arrangement, noncash expense | 3,907 | 7,779 |
| Share based compensation included in severance expense | 847 | 0 |
| Increase (decrease) in operating lease assets and liabilities, net | -496 | -552 |
| Mortgage notes accrued interest receivable | 1,824 | 421 |
| Accounts receivable | -2,209 | 12,481 |
| Other assets | -1,318 | 4,877 |
| Accounts payable and accrued liabilities | 15,929 | -6,401 |
| Increase (decrease) in deferred revenue | 5,502 | -3,016 |
| Net cash provided by operating activities | 136,483 | 186,690 |
| Payments to acquire productive assets | 4,373 | 19,541 |
| Proceeds from sale of productive assets | 19,261 | 106,436 |
| Payments to acquire interest in subsidiaries and affiliates | 1,432 | 0 |
| Investment in mortgage notes receivable | 38,297 | 9,776 |
| Proceeds from sale and collection of mortgage notes receivable | 175 | 9,458 |
| Proceeds from promissory note receivable paydown | 980 | 279 |
| Additions to properties under development | 12,643 | 57,033 |
| Net cash used by investing activities | -36,329 | 29,823 |
| Proceeds from long-term debt facilities | 70,000 | 414,000 |
| Repayments of long-term debt | 96,000 | 484,000 |
| Deferred financing fees paid | 0 | 446 |
| Proceeds from (payment for) other financing activity | 0 | - |
| Net proceeds from issuance of common shares | 245 | 464 |
| Payment, tax withholding, share-based payment arrangement | 1 | - |
| Purchase of common shares for treasury | 0 | 9,833 |
| Dividends paid to shareholders | 73,302 | 144,091 |
| Net cash used by financing activities | -99,058 | -223,906 |
| Effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents | -124 | 414 |
| Cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect | 972 | -6,979 |
| Cash and cash equivalents at beginning of period | 35,699 | - |
| Cash and cash equivalents at end of period | 29,692 | - |
EPR PROPERTIES (EPR)
EPR PROPERTIES (EPR)